THEIA development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand – In Publication.
THEIA’s Performance Assessed using a cloud platform
Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke.
THEIA used OCTA for diagnosis of AMD
Quantification of optical coherence tomography angiography in age and age-related macular degeneration using vessel density analysis.
THIEA as multi-modal imaging detection of AMD
Multimodal Retinal Image Analysis via Deep Learning for the Diagnosis of Intermediate Dry Age-Related Macular Degeneration: A Feasibility Study.
Towards implementation of AI in New Zealand national screening program: Cloud-based, Robust, and Bespoke.
THEIA as a smoking detection tool
Detection of smoking status from retinal images; a Convolutional Neural Network study.